Cite
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial
MLA
Wing Hong Kwan, et al. “Concurrent Chemotherapy-Radiotherapy Compared with Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 20, no. 8, Apr. 2002. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ce64fee1c3271f41c43b488eb0c14770&authtype=sso&custid=ns315887.
APA
Wing Hong Kwan, Tony Mok, D.T. Chan, Maria Lai, B. Zee, S.F. Leung, Roger K.C. Ngan, Frankie Mo, Thomas W.T. Leung, F.Y. Cheung, K.W. Chiu, Winnie Yeo, W.H. Lau, Peter M.L. Teo, Paul Cheung-Lung Choi, K.T. Yuen, Kwok Hung Yu, Philip J. Johnson, H.H. Yiu, & Anthony T.C. Chan. (2002). Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 20(8).
Chicago
Wing Hong Kwan, Tony Mok, D.T. Chan, Maria Lai, B. Zee, S.F. Leung, Roger K.C. Ngan, et al. 2002. “Concurrent Chemotherapy-Radiotherapy Compared with Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 20 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ce64fee1c3271f41c43b488eb0c14770&authtype=sso&custid=ns315887.